Literature DB >> 36136323

Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery: A Systematic Review and Bayesian Network Meta-analysis.

Jeong-Yeon Cho1, Yeo Kyoung Won2, Jongyeop Park3, Jin Hyun Nam4, Ji-Yoon Hong5, Serim Min1, Nahyun Kim1, Tae-Young Chung2, Eui-Kyung Lee1, Sun-Hong Kwon1, Dong Hui Lim2,6.   

Abstract

Importance: A bayesian network meta-analysis (NMA) can help compare the various types of multifocal and monofocal intraocular lenses (IOLs) used in clinical practice. Objective: To compare outcomes of presbyopia-correcting IOLs frequently recommended in clinical practice through a bayesian NMA based on a systematic review. Data Sources: Medline (PubMed) and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched on May 15, 2021, from inception. Study Selection: Based on the research question, randomized clinical trials assessing multifocal IOLs in patients who underwent bilateral cataract extraction were searched. Nonrandomized studies, studies in patients with unilateral or contralateral cataract extractions, duplicated studies, conference abstracts, and nonpeer-reviewed articles were excluded. Data Extraction and Synthesis: Descriptive statistics and outcomes were extracted. The NMA was conducted to compare different types of IOLs. The mean differences for continuous variables, odds ratios for binary variables, 95% credible intervals (CrIs), and ranks of interventions were estimated. Main Outcomes and Measures: The outcomes examined included binocular visual acuities by distance and optical quality, including glare, halos, and spectacle independence.
Results: This NMA included 27 studies comprising 2605 patients. For uncorrected near visual acuity, trifocal IOLs (mean difference, -0.32 [95% CrI, -0.46 to -0.19]) and old bifocal diffractive IOLs (mean difference, -0.33 [95% CrI, -0.50 to -0.14]) afforded better visual acuity than monofocal IOLs. Regarding uncorrected intermediate visual acuity, extended depth-of-focus IOLs provided better visual acuity than monofocal IOLs. However, there were no differences between extended depth-of-focus and trifocal diffractive IOLs in pairwise comparisons. For uncorrected distant visual acuity, all multifocal IOLs were comparable with monofocal IOLs. There were no statistical differences between multifocal and monofocal IOLs regarding contrast sensitivity, glare, or halos. Conclusions and Relevance: For patients considering a multifocal IOL due to presbyopia, bilateral implantation of a trifocal IOL might be an optimal option for patients without compromising distant visual acuity.

Entities:  

Year:  2022        PMID: 36136323      PMCID: PMC9501783          DOI: 10.1001/jamaophthalmol.2022.3667

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   8.253


  52 in total

1.  Effectiveness of multifocal and monofocal intraocular lenses for cataract surgery and lens replacement: a systematic review and meta-analysis.

Authors:  Sumitra S Khandelwal; Jason J Jun; Selene Mak; Marika Suttorp Booth; Paul G Shekelle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-10       Impact factor: 3.117

2.  Extended Depth of Focus Versus Monofocal IOLs: Objective and Subjective Visual Outcomes.

Authors:  Emilio Pedrotti; Chiara Chierego; Pietro Maria Talli; Federico Selvi; Alice Galzignato; Enrico Neri; Guido Barosco; Andrea Montresor; Anna Rodella; Giorgio Marchini
Journal:  J Refract Surg       Date:  2020-04-01       Impact factor: 3.573

3.  Multifocal versus monofocal intraocular lenses for age-related cataract patients: a system review and meta-analysis based on randomized controlled trials.

Authors:  Kai Cao; David S Friedman; Shanshan Jin; Mayinuer Yusufu; Jingshang Zhang; Jinda Wang; Simeng Hou; Guyu Zhu; Bingsong Wang; Ying Xiong; Jing Li; Xiaoxia Li; Hailong He; Lijing Chai; Xiu Hua Wan
Journal:  Surv Ophthalmol       Date:  2019-03-06       Impact factor: 6.048

Review 4.  Multifocal versus monofocal intraocular lenses after cataract extraction.

Authors:  Samantha R de Silva; Jennifer R Evans; Varo Kirthi; Mohammed Ziaei; Martin Leyland
Journal:  Cochrane Database Syst Rev       Date:  2016-12-12

5.  Postoperative visual performance with a bifocal and trifocal diffractive intraocular lens during a 1-year follow-up.

Authors:  Peter Mojzis; Lucia Kukuckova; Katarina Majerova; Peter Ziak; David P Piñero
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

6.  Visual Performance With Bifocal and Trifocal Diffractive Intraocular Lenses: A Prospective Three-Armed Randomized Multicenter Clinical Trial.

Authors:  Hakan Kaymak; Detlev Breyer; Jorge L Alió; Beatrice Cochener
Journal:  J Refract Surg       Date:  2017-10-01       Impact factor: 3.573

7.  Comparison of outcomes with multifocal intraocular lenses: a meta-analysis.

Authors:  Béatrice Cochener; Antoine Lafuma; Babak Khoshnood; Laurène Courouve; Gilles Berdeaux
Journal:  Clin Ophthalmol       Date:  2011-01-07

8.  Comparison of postoperative visual performance between bifocal and trifocal intraocular Lens based on randomized controlled trails: a meta-analysis.

Authors:  Shanshan Jin; David S Friedman; Kai Cao; Mayinuer Yusufu; Jingshang Zhang; Jinda Wang; Simeng Hou; Guyu Zhu; Bingsong Wang; Ying Xiong; Jing Li; Xiaoxia Li; Hailong He; Xiuhua Wan
Journal:  BMC Ophthalmol       Date:  2019-03-14       Impact factor: 2.209

9.  Prospective evaluation of visual outcomes with three presbyopia-correcting intraocular lenses following cataract surgery.

Authors:  Re Ang; Ga Martinez; Em Cruz; Aa Tiongson; Ag Dela Cruz
Journal:  Clin Ophthalmol       Date:  2013-09-17

10.  Clinical Results of Diffractive, Refractive, Hybrid Multifocal, and Monofocal Intraocular Lenses.

Authors:  Agnieszka Dyrda; Ana Martínez-Palmer; Daniel Martín-Moral; Amanda Rey; Antonio Morilla; Miguel Castilla-Martí; Janny Aronés-Santivañez
Journal:  J Ophthalmol       Date:  2018-06-25       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.